COMPASS Pathways (CMPS) Scheduled to Report Q3 2026 Earnings
COMPASS Pathways plc (CMPS) is set to release its third-quarter 2026 earnings results on Tuesday, November 3rd, prior to the market opening. Market analysts have established a consensus earnings per share (EPS) estimate of -$0.33 for the quarter. The company continues to focus on its clinical pipeline, specifically targeting the completion of its Treatment-Resistant Depression (TRD) New Drug Application (NDA) in Q4. Looking further ahead, COMPASS anticipates the launch of its product COMP360 in the first half of 2027.
Tickers: $CMPS